Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study
Anna Moltó(Inserm), Maxime Dougados(Inserm), Carlomaurizio Montecucco(University of Pavia), N. Hajjaj‐Hassouni(International University of Rabat), Ш. Ф. Эрдес(Russian Academy of Sciences), F. van Gaalen(Leiden University Medical Center), Filip Van den Bosch(Ghent University Hospital), Mitsumasa Kishimoto(Kyorin University), Atul Deodhar(Oregon Health & Science University), Bassel Elzorkany(Cairo University), Eduardo Collantes‐Estévez(Hospital Universitario Reina Sofía), Helena Marzo‐Ortega(University of Leeds), Salih Özgöçmen(Tokat Gaziosmanpaşa Üniversitesi), Peter Cheung(Délégation Paris 5), Adrien Etcheto(Délégation Paris 5), Walter P. Maksymowych(University of Alberta), José A. Maldonado‐Cocco(Instituto Nacional de Rehabilitación Psicofísica), Pedro Machado(Fermi National Accelerator Laboratory), Wilson Bautista‐Molano(Military University Nueva Granada), Tae‐Hwan Kim(Yonsei University), Jieruo Gu(Sun Yat-sen University), Désirée van der Heijde(Leiden University Medical Center), R Burgos-Vargas(Hospital General de México), Robert Landewé(Zuyderland Medisch Centrum), Shue‐Fen Luo(Chang Gung University), Uta Kiltz(Rheumazentrum Ruhrgebiet)
Cited by 268
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
|The Lancet|2004|1.8k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
|Annals of the Rheumatic Diseases|2017|1.6k